Deepbridge raises £1m in its latest SEIS funding round
- On March 17, 2021
- By GrowthInvest Marketing
Deepbridge’s Life Science Fund sees subscriptions rise 40% over the last 6 months, compared with the same time period in the previous year.
Dr Savvas Neophytou, Partner and Head of Life Sciences at Deepbridge Capital, “The past twelve months has shone a spotlight on the world-leading innovation in the UK life sciences sector like never before, and we have understandably seen significant growth in investor interest as a result.”
The Deepbridge Life Sciences SEIS enables private investors to access a portfolio of early-stage companies within the UK’s vibrant life sciences sector, whilst benefiting from the generous potential tax reliefs available via the Government’s Seed Enterprise Investment Scheme (SEIS).
Click here to read the full article.
GET IN TOUCH!
MAIL US
enquiries@growthinvest.comCALL US
020 7071 3945FOLLOW US ON
Throughout our site you will find links to external websites. Although we make every effort to ensure these links are accurate, up to date and relevant, we cannot take responsibility for pages maintained by external providers.
GrowthInvest is a trading name of EIS Platforms Limited. EIS Platforms Limited (FRN: 694945) is an appointed representative of Sapphire Capital Partners LLP (FRN:565716) which is authorised and regulated by the Financial Conduct Authority in the UK.
All rights reserved 2024 @ growthinvest